Ph.D., Pharmacology, University of Houston, Houston, TX (December 2014)
Thesis: “The role of the β2-adrenoceptor activation in development of the asthma phenotype ”
BS., Pharmacy, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (2005-2009)
Thesis: “Non-compliance to Medication Regimen in the Kumasi Metropolis” First Class Division
Prof. Alexander Arnold
Identification of novel therapies for asthma
Thanawala VJ*, Forkuo GS*, Stallaert W, Leff P, Bouvier M,Bond RA. Ligand bias prevents class equality among beta-blockers. Curr Opin Pharmacol 2014 Jun;16:50-7. doi: 10.1016/j.coph.2014.03.002. Epub 2014 Mar 27
Forkuo GS, Thanawala VJ, Al-Sawalha N, Bond RA,Walker JK. Reply: Adverse effects of long-acting beta-agonists on airway hyperresponsiveness. Am J Respir Cell Mol Biol. 2013 Sep; 49(3): 502
Vollert C*, Forkuo GS*, Bond RA, Eriksen JL. Chronic treatment with DCPCX, an adenosine A (1) antagonist, worsens long-term memory. Neurosci Lett. 2013 Aug 26; 548: 296-300. doi: 10.1016/j.neulet.2013.05.052.
Thanawala VJ, Forkuo GS, Al-Sawalha N, AzzegaghZ, NguyenLP, Eriksen JL, Tuvim MJ, Lowder TW, Dickey BF, Knoll BJ, Walker JKL, and Bond RA. Beta2-adrenoceptor agonists are required for development of the Asthma Phenotype in a murine model. Am J Respir Cell Mol Biol Feb 2013;48:220-229.
Vaidehi J. Thanawala, Daniel Valdez, Radhika Joshi, Gloria S. Forkuo, Brian J. Knoll Richard A. Bond Biased Signaling by Beta-blockers Predicts Effectiveness on Murine Asthma Model. JCI (sent for review)
Manuscript in preparation
S. Forkuo, V. J. Thanawala, N. Al-Sawalha, D. Valdez, R. Joshi R. B. Penn, J. L. Eriksen, B. J. Knoll, J. K. L. Walker, and R.A. Bond. Amplification of the β2-adrenoceptor Gs-cAMP pathway attenuates the asthma phenotype in a murine model. Br J Pharmacol 2014 (to be sent for review)